MetaboVia Ingredients: Research on Metabolism & Body Composition
Published: September 25, 2026, Written by Nalin Siriwardhana, PhD, FACN Published by NUTRITUNES® Science of Supplements
Disclosure: MetaboVia is formulated and sold by NUTRITUNES®, which publishes this article. This is an evidence review of published research on the formula's individual ingredients, not a clinical evaluation of MetaboVia. MetaboVia itself has not been clinically tested as a finished formula for weight loss or body-composition outcomes.
Founder's Note
The weight-management aisle often sells certainty that the science does not have. Most ingredients in this category have been studied, but usually in small, short trials with modest average effects. People deserve to see what those studies found, how large the effects were, and where the gaps are, before they decide anything.
The Short Answer
MetaboVia is a dietary supplement containing berberine (as Metaberine™, a Berberis aristata extract), chromium picolinate, Gymnema sylvestre leaf extract, banaba leaf extract, and Grains of Paradise seed extract. Each ingredient has been studied in humans in relation to aspects of carbohydrate metabolism, lipid metabolism, or energy expenditure. Where body weight was measured, meta-analyses of berberine and chromium reported average differences of under 1 kg compared with placebo. The finished formula has not been tested in a clinical trial.
What We Know (and Don't Know)
| What the Research Shows | What Remains Uncertain |
|---|---|
| Berberine and chromium meta-analyses report small average weight differences versus placebo, each under 1 kg [1,3] | Whether combining these ingredients adds benefit beyond any single one |
| Metaberine™ was studied for post-meal glucose response over 14 days [5] | Whether ingredient results apply at the amounts in MetaboVia |
| Grains of Paradise increased energy expenditure only in people with active brown fat [7] | Long-term outcomes, and why some people respond and others do not |
Why Carbohydrate and Fat Metabolism Are Connected
After a meal, insulin rises, cells take up glucose, and the release of stored fat slows. Between meals and during exercise, insulin falls and fatty acids become a larger fuel source. The ability to shift between carbohydrate and fat as fuel is often described as metabolic flexibility. This interconnected regulation provides a biological rationale for considering multiple metabolic pathways, but mechanism alone does not show that combining ingredients produces greater clinical benefit. Diet research makes a related point: in the 12-month DIETFITS trial of 609 adults, healthy low-fat and healthy low-carbohydrate diets produced no significant difference in weight change [10].
Important: ingredient evidence is not finished-formula evidence. The studies below tested individual ingredients, not MetaboVia. Dose, standardization, formulation, population, study length, and bioavailability all shape results, so ingredient findings cannot be assumed to occur with the finished product.
What Clinical Research Shows About Each Ingredient
What Does the Research Show About Berberine and Weight Management?
Berberine has been studied for its interaction with AMPK, a cellular energy sensor. A 2025 meta-analysis of 23 RCTs reported an average weight difference of −0.88 kg versus control (95% CI −1.36 to −0.39), with small reductions in BMI and waist circumference [1]. An earlier meta-analysis of 10 RCTs found no significant change in body weight [2]. Findings vary across studies, and reviewers flagged gaps in blinding and randomization. These trials mostly used standard berberine at higher daily amounts than MetaboVia's 200 mg.
Metaberine™ is a formulated form of berberine designed to enhance delivery. In a 14-day randomized, double-blind, placebo-controlled crossover trial, 36 adults took 200 mg daily, the same amount as in MetaboVia. The trial found a smaller rise in blood glucose after a standardized glucose drink compared with placebo [5]. Participants had fasting glucose of 100–125 mg/dL, so the findings may not apply to people with lower fasting glucose. The trial did not measure body weight, and two of its authors are affiliated with the ingredient developer. Metaberine™'s reported absorption advantage comes from a rat study and has not been confirmed in humans [6].
What Does the Research Show About Chromium and Weight?
Chromium plays a role in normal insulin signaling. A meta-analysis of 11 RCTs found an average weight difference of −0.50 kg versus placebo (95% CI −0.97 to −0.03), with high heterogeneity and uncertain clinical relevance [3]. MetaboVia's 200 mcg is at the lower end of the amounts studied.
What Does Research Show About Gymnema Sylvestre?
In a 12-week randomized, placebo-controlled trial of 24 adults with multiple metabolic risk factors, 600 mg daily was associated with lower body weight and BMI within the Gymnema group. The abstract did not report a significant difference versus placebo, and insulin sensitivity did not change [4]. MetaboVia provides 100 mg, so these findings cannot be directly applied to this formula.
What Is Banaba Leaf?
Banaba supplies corosolic acid, studied for its role in cellular glucose uptake. Human studies are mostly small and short-term, focus on glucose response, and include limited body-weight data [9]. MetaboVia provides 300 mg (1% corosolic acid); studies used varied preparations, so direct dose comparison is limited.
Does Grains of Paradise Increase Energy Expenditure?
In a randomized crossover study of 19 men, a single 40 mg dose increased energy expenditure only in participants with detectable brown fat [7]. The 2013 study used a 40 mg extract standardized to 12.5% 6-paradol, which corresponds to the same extract amount and 6-paradol standardization used in MetaboVia. However, the two extracts have not been confirmed as identical overall. In a 4-week trial of 19 young women, 30 mg daily reduced visceral fat area, while total body fat and body weight did not change [8].
Comparing the Evidence
| Ingredient | Amount in MetaboVia | Best Human Evidence | Weight-Related Outcome | Evidence Strength |
|---|---|---|---|---|
| Berberine (as Metaberine™, Berberis aristata extract) | 200 mg | Meta-analysis, 23 RCTs [1]; Metaberine™ RCT, n = 36 [5] | About −0.9 kg average (standard berberine); not measured for Metaberine™ | Moderate; preliminary for Metaberine™ |
| Chromium (as chromium picolinate) | 200 mcg | Meta-analysis, 11 RCTs [3] | About −0.5 kg average | Low to moderate |
| Gymnema sylvestre leaf extract (25% gymnemic acids) | 100 mg | One RCT at 600 mg/day, n = 24 [4] | Within-group only; no reported difference vs placebo | Low |
| Banaba leaf extract (1% corosolic acid) | 300 mg | Small trials; review [9] | Limited data | Low |
| Grains of Paradise seed extract (12.5% 6-paradol) | 40 mg | Two small RCTs, n = 19 each [7,8] | Visceral fat area reduced; weight unchanged | Low |
A similar labeled amount does not guarantee an equivalent effect, because composition, bioavailability, and study population all matter.
Can a Metabolic Supplement Treat Weight-Related Health Conditions?
No. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk with your healthcare provider first if you have a health condition, take medication (especially medication that affects blood glucose), or are pregnant or nursing; berberine may interact with some medications. Reported adverse effects were generally mild, with digestive effects among those reported in the studies reviewed.
The Science-Based Conclusion
What the research suggests: Each ingredient has been studied in relation to carbohydrate metabolism, lipid metabolism, or energy expenditure, but the strength of that evidence differs substantially. Where weight was measured, average effects were modest and individual responses varied. The science behind the formula rests on this ingredient-level research; the combined formula itself has not been clinically tested.
The thoughtful approach: A calorie-appropriate, high-quality diet, adequate protein, regular activity, and consistent sleep have the strongest evidence for healthy body composition. A supplement is best viewed as a small addition to that foundation, not a substitute for it.
Your next steps:
- Build the lifestyle foundation first.
- Choose products with fully disclosed amounts, and compare those amounts with the ones used in studies.
- Talk with your healthcare provider, especially if you take medication.
- Keep expectations realistic: research evaluates outcomes over weeks to months.
Frequently Asked Questions
Has MetaboVia been clinically tested? No. The evidence in this article comes from studies of its individual ingredients, not the finished formula.
How much weight did people lose in the berberine and chromium studies? Meta-analyses of berberine and chromium reported average weight differences of less than 1 kg compared with placebo. These effects were statistically significant but modest, and results varied across studies [1,3].
Does Grains of Paradise work for everyone? Not necessarily. In one study, the increase in energy expenditure appeared only in people with detectable brown fat [7].
Can a metabolic supplement replace medical treatment or prescribed medication? No. Supplements are not intended to treat any condition. Consult your healthcare provider before combining any supplement with medication.
Are these ingredients safe to take long term? They were generally well tolerated in short-term trials, most lasting 12 weeks or less. Long-term data are limited, so medical guidance is advisable.
Learn More About the Formula
The MetaboVia product page shows the full Supplement Facts panel. There are no proprietary blends.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
About the Author
Dr. Nalin Siriwardhana, PhD, FACN, is the founder and Chief Scientific Officer of NUTRITUNES®. He holds a PhD in nutritional science, is a Fellow of the American College of Nutrition, and has more than 20 years of experience in nutrient research, science-based product development, and medical affairs. Read his full profile →
References
- Vahed E, et al. International Journal of Obesity. Published online November 2025. PMID: 41310257
- Xiong P, Niu L, Talaei S, et al. Complementary Therapies in Clinical Practice. 2020. PMID: 32379652
- Onakpoya I, Posadzki P, Ernst E. Obesity Reviews. 2013;14(6):496–507. doi:10.1111/obr.12026
- Zuñiga LY, González-Ortiz M, Martínez-Abundis E. Journal of Medicinal Food. 2017;20(8):750–754. doi:10.1089/jmf.2017.0001
- Jeyakodi S, Krishnakumar A, Naik DN, Hussain MM, Thomas JV. International Journal of Clinical Trials. 2026;13(3):270–282. doi:10.18203/2349-3259.ijct20262501
- Kiran DA, et al. Cureus. 2026;18(5). Animal pharmacokinetic study. doi:10.7759/cureus.109791
- Sugita J, Yoneshiro T, Hatano T, et al. British Journal of Nutrition. 2013;110(4):733–738. PMID: 23308394
- Sugita J, Yoneshiro T, Sugishima Y, et al. Journal of Nutritional Science and Vitaminology. 2014;60(1):22–27. PMID: 24759256
- Stohs SJ, Miller H, Kaats GR. Phytotherapy Research. 2012;26(3):317–324. PMID: 22095937
- Gardner CD, Trepanowski JF, Del Gobbo LC, et al. JAMA. 2018;319(7):667–679. PMID: 29466592
This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals regarding your specific health concerns and before starting any supplementation regimen. The statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
